- FDA Committee Discussion Opines Men Under 40 at Greater Risk of Vaccine-Related Myocarditis than COVID Itself.
by BLUEAPPLES, https://www.zerohedge.com/
Following the release of the Biden administration’s six-step plan to increase vaccination rates across the country, it seemed that their charge toward a de facto national vaccine mandate had reached terminal velocity. Yet, in advance of the administration’s decision to green light booster shots to address the waning efficacy of vaccines, their steadfast effort reached unexpected resistance from an even more unexpected source. On September 18, the FDA declared that its authorization for the expansion of booster shots beyond the immunocompromised would only apply to persons 65 years or older. The FDA committee which authorized the administration of boosters for that 65+ demographic by a 18-0 vote issued an equally resounding vote against approving the measure for people below 65 by a vote of 16-3.
At best, the decision was made at a time where data on the efficacy of boosters does not clearly support policy making expanding their authorization. When pressed on that very issue, CDC Director Rochelle Wallensky didn’t offer a resounding endorsement when she stated that “so there’s actually hope, we don’t have data yet.” Another less than stellar endorsement of expanding boosters came from a study published in the New England Journal of Medicine which examined the efficacy of the Israeli government’s booster initiative which began on July 30. While the study determined that the rate of infection was lower among recipients of booster shots, the threshold for the enhanced protection they achieved was only measured at a period of 12 days following the third dosage. Even then, the rate of infection only fell by around 11%. While these instances highlight the uncertainty of the long-term success of the Biden administrations booster initiative, the FDA panel discussion on the issue did highlight one thing with much greater certainty — the risks of vaccination side effects can outweigh the risk of COVID-19 themselves.